Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Islam. Boko Haram. Terrorism. Prof Hussein Solomon offers insight.
2014-09-04

 

 Photo: en.wikipedia.org

Prof Hussein Solomon introduction: video

When it comes to politics, there are lots of negative talk, but without any action or solutions.

However, with Prof Hussein Solomon, Senior Professor at the UFS’s Department of Political Science, there is not a lot of talk without solutions, but great activity regarding research work published on Islam, the Middle East, Boko Haram and environmental issues in Africa.

Prof Solomon’s most recently published article, Five Lessons Learned from Ejecting Islamists in Mali, was published in the Research on Islam and Muslims in Africa (RIMA) Policy Papers on 1 September 2014.
(https://muslimsinafrica.wordpress.com/2014/09/01/five-lessons-learned-from-ejecting-islamists-in-mali-professor-hussein-solomon/ ).

“The terrorist threat is mounting with each passing day in Africa with Islamist terror groups exploiting the ungoverned spaces, the availability of weapons, porous borders, an incompetent security apparatus and corruption in the political establishment,” Prof Solomon writes in this paper.

“It is therefore important, to explore cases where attempts have been made to dislodge the Islamists with a view to learn lessons so that future interventions do not repeat the failures of the past. This paper explores the intervention and lessons which could be learned from French and Economic Community of West African States (ECOWAS) attempts to oust Islamists in northern Mali in 2013.”

Prof Solomon holds a DLitt et Phil (Political Science) from the University of South Africa (UNISA). In 2011, he was Visiting Professor at the Osaka School for International Public Policy (OSIPP). In 2007 and 2010 he was Visiting Professor at the Global Collaboration Centre at Osaka University in Japan and in 2008 he was Nelson Mandela Chair of African Studies at Jawahrlal Nehru University in New Delhi, India. In 1994, he was Senior Visiting Fellow at the Department of War Studies, King’s College at the University of London. He is currently a Visiting Fellow at the MacKinder Programme for the Study of Long-Wave Events at the London School of Economics and Political Science in the United Kingdom.

He is also a Senior Associate for the Israeli-based think tank Research on Islam and Muslim in Africa and a Senior Analyst for WikiStrat.

More articles by Prof Solomon:

Boko Haram and the case of the abducted school girls
http://muslimsinafrica.wordpress.com/2014/05/14/reinvigorating-the-fight-against-boko-haram-professor-hussein-solomon/

Australian Broadcasting Corporation interview on Boko Haram
http://www.abc.net.au/radionational/programs/counterpoint/boko-haram/5657882  

Reflections on Inga 3 and Beyond
www.saccps.blogspot.com  

Nile and Okavanga River Basins (pdf)
 
Nigeria’s Boko Haram: Beyond the rhetoric (pdf)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept